...
首页> 外文期刊>Journal of Pharmacy and Bioallied Sciences >An in vivo and in vitro investigation of the effect of Aloe vera gel ethanolic extract using animal model with diabetic foot ulcer
【24h】

An in vivo and in vitro investigation of the effect of Aloe vera gel ethanolic extract using animal model with diabetic foot ulcer

机译:糖尿病足溃疡动物模型对芦荟凝胶乙醇提取物作用的体内外研究

获取原文
           

摘要

Aim:To examine the preventive effect of Aloe vera gel ethanolic extract using diabetic foot ulcer (DFUs) protocol in Wistar rats.Materials and Methods:Male Wistar rats were divided into untreated control (Group I), untreated DFUs (Group II), DFUs treated with A. vera gel ethanolic extract (Group III), DFUs treated with topical A. vera gel (Group IV), DFUs treated with A. vera gel ethanolic extract and topical A. vera gel (Group V). The rats in the treatment groups were daily administered the A. vera gel and ethanolic extract for 9 days. Fasting blood glucose levels and percentage of wound ulcer contraction were measured on day 3, 6, and 9.Statistical Analysis used:The results are expressed as a mean ± Standard Error Mean (SEM). Data were analyzed using one-way analysis of variance (ANOVA) after Newman–Keuls test. P < 0.05 were considered statistically significant in all cases.Results:Oral administration of A. vera gel ethanolic extract at a dose of 300 mg/kg body weight per day to diabetic rats for a period of 9 days resulted in a significant reduction in fasting blood glucose and a significant improvement in plasma insulin. Topical application of A. vera gel at a dose 30 mg/kg body weight per day to streptozotocin (STZ)-induced diabetic rats for a period of 9 days resulted in no change in blood glucose and plasma insulin. Oral administration as well as topical application of A. vera gel ethanolic extract and gel significantly reduced the blood glucose, improved the plasma insulin, and significantly increased DNA and glycosaminoglycans (GAGs) to improve the wound ulcer healing as well as the breaking strength on day 9.Conclusions:Present findings provide a scientific rationale for the use of A. vera gel ethanolic extract, and showed that the gel attenuated the diabetic foot wound in rats.
机译:目的:探讨糖尿病足溃疡(DFUs)方案对芦荟凝胶乙醇提取物对Wistar大鼠的预防作用。材料与方法:雄性Wistar大鼠分为未治疗对照组(I组),未治疗DFU(II组),DFUs。 A. vera gel乙醇提取物(第III组)处理的DFU,A。vera gel局部用凝胶剂(第IV组),A。vera gel乙醇提取物和局部A. vera凝胶(D组)处理的DFU。每天给治疗组的大鼠施用维拉凝胶和乙醇提取物,持续9天。在第3、6和9天测量空腹血糖水平和伤口溃疡收缩百分比,使用统计分析:结果表示为平均值±标准误差平均值(SEM)。在Newman–Keuls检验后,使用单向方差分析(ANOVA)分析数据。在所有情况下,P <0.05均具有统计学意义。结果:每天以300 mg / kg体重的剂量口服A. vera凝胶乙醇提取物给糖尿病大鼠,持续9天,导致禁食显着减少血糖和血浆胰岛素的显着改善。每天以30 mg / kg体重的剂量将A. vera凝胶局部施用到链脲佐菌素(STZ)诱导的糖尿病大鼠中9天,结果血糖和血浆胰岛素无变化。口服给药以及维拉曲霉凝胶乙醇提取物和凝胶的局部应用显着降低了血糖,改善了血浆胰岛素,并显着提高了DNA和糖胺聚糖(GAG)的含量,从而改善了伤口溃疡的愈合以及每日的断裂强度9.结论:目前的发现为A. vera凝胶乙醇提取物的使用提供了科学依据,并表明该凝胶减轻了大鼠糖尿病足的伤口。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号